Reproductive Health News

Long-term embryo cryopreservation was not associated with live birth rates for women undergoing elective or nonelective frozen embryo transfers, according to an analysis published in the American Journal of Obstetrics and Gynecology.

Mode of delivery did not affect self-perceived sexual life satisfaction overall or at any time postpartum, according to cohort study results published in the American Journal of Obstetrics and Gynecology.

Metformin exposure during pregnancy was not associated with adverse childhood neurodevelopmental outcomes up to age 14 years, according to a systematic review and meta-analysis published in the American Journal of Obstetrics and Gynecology.

Infants born to mothers vaccinated against COVID-19 during the omicron wave had decreased risks for preterm birth and adverse neonatal outcomes, according to results of the INTERCOVID-2022 study.

On Thursday, the U.S. Supreme Court ruled 9-0 that access to mifepristone for medication abortion remains legal including rules adopted since 2016 loosening original dispensing requirements and gestation limits.

BOSTON — Women exposed to a class of endocrine-disrupting chemicals known as PFAS may be more likely to struggle with breastfeeding, whereas the health effects of infant exposure to PFAS via breastmilk remain unknown, a speaker said.

BOSTON — Evidence suggests hyperandrogenism is associated with changes in the gut microbiome in women with polycystic ovary syndrome and the gut microbiome may play a causal role in PCOS metabolic dysregulation, according to a speaker.

PHILADELPHIA — Consistently missed periods brought on by intense exercise, disordered eating or stress in young women can lead to multiple consequences, including endothelial dysfunction and increased CVD risk, according to a speaker.

BOSTON — People with primary ovarian insufficiency have higher risk for breast cancer and borderline increased risk for ovarian cancer compared with the general population, and risks for some cancers extend to their relatives, data show.

Women who use contraceptive pills may be at a higher risk for frontal fibrosing alopecia, according to a study.